Fundraising Fox

Paragon Therapeutics

Philadelphia, US · Founded 2021 · Delaware corporation

Biotech

Founders & leadership

ET
Evan ThompsonNamed on SEC filing

Board

PH
Peter HarwinBoard director

Reported raises · per SEC filings

Form D private placements

$10M disclosed across 1 round · 2021

▶$10MraisedMay 2021 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter HarwinDirector, Promoter
  • Evan ThompsonExecutive Officer, Promoter
Offering amount
$10M
Amount sold
$10M
First sale
Apr 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Startup Korsana Bio Reveals $175M Raised for a Better Brain-Penetrating Alzheimer’s Drug - MedCity Newsmedcitynews.com · Feb 2026Paragon Therapeutics Announces Oruka Therapeutics Has Entered into Merger Agreement with ARCA biopharma to Advance Novel Treatments for Chronic Skin Diseasesprnewswire.com · Apr 2024Investors funnel $275 million into Paragon Therapeutics-spinoutstatnews.com · Apr 2024

Frequently asked questions

How much funding has Paragon Therapeutics raised?
Paragon Therapeutics has disclosed $10M raised across 1 round.
Where is Paragon Therapeutics headquartered?
Paragon Therapeutics is headquartered in Philadelphia, US.